Paolo Di Giorgio

Position: Head of research & development
Organization: Angelini Pharma
Country: Italy

Life Sciences executive with over 15 years of experience in R&D, venture capital, business development, program leadership and management, coaching and mentoring in a global environment.

He is currently leading the External Innovation and Corporate Ventures groups of Angelini Pharma: his team is managing integrated drug discovery programs, conducting search and evaluation of companies operating in the CNS and rare diseases space, investing in funds and start-ups.

Their recent investments includes: a participation in Argobio, a European venture studio based in Paris; the co-founding of the Angelini Lumira Bioscience Fund (ALBF), a fund focused in early stage CNS/rare diseases companies, managed by Lumira Ventures; and an investment in Pretzel Therapeutics.